Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.
about
Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Addition of an antiangiogenic ...... dvanced biliary tract cancers.
@en
type
label
Addition of an antiangiogenic ...... dvanced biliary tract cancers.
@en
prefLabel
Addition of an antiangiogenic ...... dvanced biliary tract cancers.
@en
P2093
P2860
P1476
Addition of an antiangiogenic ...... dvanced biliary tract cancers.
@en
P2093
Bertrand Brieau
Catherine Brezault
François Goldwasser
Johann Dréanic
Marie Bréchon
Marie Dior
Marie-Anne Guillaumot
Romain Coriat
P2860
P2888
P304
P356
10.1007/S10637-017-0492-6
P50
P577
2017-08-01T00:00:00Z
P6179
1090939888